Drag-reducing polyethylene oxide improves microcirculation after hemorrhagic shock

J Surg Res. 2016 May 1;202(1):118-25. doi: 10.1016/j.jss.2015.12.044. Epub 2016 Jan 6.

Abstract

Background: Despite resuscitation after trauma, microcirculatory abnormalities are known to persist in post-shock multiorgan dysfunction. The high-molecular weight polymer polyethylene oxide (PEO) (>10(6) Da), a classic drag-reducing polymer, can improve hemorrhagic shock (HS)-induced hemodynamic abnormalities in rats.

Materials and methods: We examined the effects of PEO on microcirculation and on changes in multiple organs after shock. After the spinotrapezius muscle was prepared, HS was induced in Sprague-Dawley rats. Drug administration (normal saline or PEO) was performed 2 h after shock followed by infusion of shed blood.

Results: The velocity, blood flow, and functional capillary density in the shock + PEO group were significantly higher than those in the shock + normal saline group. Moreover, the kidney, liver, and lung function was improved, resulting in prolonged survival time. Our findings indicate that intravenous infusion of PEO can ameliorate shock-associated organ dysfunction and prolong survival time in severe HS, which may be a result of increased arteriolar blood velocity, blood flow, and functional capillary density.

Conclusions: PEO could have potential clinical application in the treatment of shock-induced multiorgan dysfunction.

Keywords: Drag-reducing polymer (DRP); Hemorrhagic shock; Microcirculation; Polyethylene oxide; Sprague–Dawley rats.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Infusions, Intravenous
  • Kidney / blood supply
  • Kidney / drug effects
  • Liver / blood supply
  • Liver / drug effects
  • Lung / blood supply
  • Lung / drug effects
  • Male
  • Microcirculation / drug effects*
  • Polyethylene Glycols / pharmacology
  • Polyethylene Glycols / therapeutic use*
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Shock, Hemorrhagic / drug therapy*
  • Shock, Hemorrhagic / physiopathology
  • Surface-Active Agents / pharmacology
  • Surface-Active Agents / therapeutic use*
  • Treatment Outcome

Substances

  • Surface-Active Agents
  • Polyethylene Glycols